MAPK1 and Alzheimer disease: Then, through a protein–protein interaction network, the molecular docking indicated a strong binding affinity between albiflorin and mitogen‐activated protein kinase‐1 (MAPK1) or extracellular signal‐regulated kinase (ERK), suggesting that these proteins may serve as potential targets for anti‐AD activity.